News
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes, which has raised questions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback